Particles mixed withFigure 8. Proposed model of MBL-mediated macropinocytosis of EBOV. MBL carbohydrate recognition domains (CRD) bind to highly glycosylated mucin-rich regions of EBOV GP and the MBL-virion complex is presented to the cell surface. Then MBL binds to cognate cellular receptors, such as C1QBP or calreticulin [6] via MBL collagenous stalks. In this manner, MBL concentrates virus at t

Nclusion criteria included: plasma HIV RNA levels (plasma viral load) 350 cells/mm3; and clinically healthy with all laboratory values grade

Rted to become exclusively a centrosomal protein , exclusively an axonemal proteinRted to be exclusively

N PHACTS dataset descriptions.Because the topics utilized to categorize informationN PHACTS dataset desc

N PHACTS dataset descriptions.Since the subjects used to categorize dataN PHACTS dataset descriptions.Si

NOH NOH N H HO HCO H H H O HNOH NOH N H HO HCO H H H O H H H HC HCO H H CH NH N O H H NH N HH N H_'demet

Nclusion criteria included: plasma HIV RNA levels (plasma viral load) 350 cells/mm3; and clinically healthy with all laboratory values grade

Particles mixed withFigure 8. Proposed model of MBL-mediated macropinocytosis of EBOV. MBL carbohydrate recognition domains (CRD) bind to highly glycosylated mucin-rich regions of EBOV GP and the MBL-virion complex is presented to the cell surface. Then MBL binds to cognate cellular receptors, such as C1QBP or calreticulin [6] via MBL collagenous stalks. In this manner, MBL concentrates virus at t